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EFFECT OF INTRAVASCUiAR COLLAGEN I  ATHEROSCLEROTIC 
PRInATgS. 
J. Antonio G. Lopez, X.D., John C. Yoak, M.D., Hark L. 
Armstrong, M.D., Donald J. Piel;ors B.S., Donald D. 
Heirtad, H.D. VA Medical Center and University of Iowa, 
Iowa City, IA 
Aggregation of platelets at endothelial sites releases 
several potent vasodilator and vasoconstrictor 
substances. Previous studies have examined responses to 
these substances, but not to activation of platelets in 
vivo . We atudied vasomotor responses of cynomolgus 
monkeys to activation of platelets in vivo by infusion of 
collagen. Purified bovine collagen (10 and 50 &min) 
was infused i.a. for 9 minutes into the perfused hind 
limb of normal nonkeys (n-19) and monkeys fed an 
rtherogenic diet (AS) for 19 months (n-13). Resistance 
of the total limb and large arteries was determined at 
constant flow. first 1-2 minutes of infusion 
of collagen, there vas dilatation of small arteries in N 
and AS monkeys, probbbly mediated by ADP. Vasodilatation 
wan inpaired in AS monkeys (fl .OS vs. N) . After 
approximately 5 minutes of infusion of collagen, there 
vas constriction of large arteries, which was potentiated 
30fold in As monkeys (p~O.05 vs. N). Thus, when 
aggregate in vivo, the initial response is 
tion, but vaooconstriction then predominates. 
sodilator responses bd greatly augments 
vrsoconstrlction to platelet products, probably ss a 
result of endothelial dysfunction. Augmented 
vasoconstrictor responses to aggregation of platelets in 
vivo explain the propensity for vasospasm in AS, 
particularly when collagen is exposed at the vascular 
interface. 
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endothelin-1, 5-WT did not potent& contractions to 
norepinephrine. 
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norepinephrine 
may be imporla 
EFFECT OF ASPIRIN ON LOCAL PROStAQLANOlN PROOUC- 
TION AND SEROTONIN ACCUMULATION IN A CANINE 
MODEL WITH CORONARY CYCLIC FLOW VARIATIONS 
Sheng-Kun Yea, M.D., Claude Benedict. M.D.. Ph.D.. Merk 
Rosalowaky, Ph.D.. Janice McNatt. Barbara Fulinska, L. Mexi- 
M.D., FACC. milian Bu& M.D., FACC. James T. Willereon. 
UT Sourhwesrern Medical Center. Oellee. Texas. 
We have reported that thromboxane A2 (TxA21 end serotonin 
(5-HTI are twc important mediators of canine coronary cyclic 
the hyporhesis that blockin 
were administered through the left atrium eo 27 dogs. Nineteen 
dogs [70X1 had CFVs aboliehed. The eynrhesis of TxA2 wes 
significantly reduced at left anterior descending coronrry 
artery [LAOI segment 
Prosracyciin production 
end endnthelial injury. 
d. 
ASA Onse [mg/kgl g-Keto-PQF 1 
1.1 In1 208 f 38 (41 125 t 27 (41 
4.8 + 1.1 In1 124 f 31 (21 58 t 38 r21 
8.2 ??4.6 + 1.1 In1 50 f 6 @I, 25 * 5 @I@ 
* Compared to ASA 1. I rig/g,, p < 0.00 1 
However, 5-HT ConcentraLions were not affected following 
all three doses OF ASA. 255.7 t 131.2 ng/ 
with stenosis end endothelial injury. 17.1 * 3.7, la.6 t 3.7. 
and 19.2 f 5.1 rig/g,, at the site proximal or 
and normei left circumflex coronary 
Thus, ASA eliminates CFVs in 70X of dog 
iehes TxAp eynrhesis at the site of coronery artery e’enoeib 
and endothslial injury. bur does not affect 5-HT eccumuletion. 
This may help explein the additional need for 8 S-HT receptor 
antagonist to compierely eliminate CFVs in some enimale 
receiving e TxA2 eynehase inhibitor or receptor entegonist. 
